Definium Therapeutics (DFTX) Intangibles (2021 - 2023)

Definium Therapeutics (DFTX) has 3 years of Intangibles data on file, last reported at $527000.0 in Q4 2023.

• Intangibles for Q4 2023 came in at $527000.0, down 85.71% year-over-year; the trailing twelve-month figure through Dec 2023 was $527000.0 (down 85.71% YoY), and the FY2023 annual result was $527000.0, down 85.71% from the prior year.
• Intangibles declined to $527000.0 in Q4 2023 per DFTX's latest filing, from $1.3 million in the prior quarter.
• Over five years, Intangibles peaked at $6.9 million in Q4 2021 and troughed at $527000.0 in Q4 2023.
• A 3-year average of $3.7 million and a median of $3.7 million in 2022 frame the typical range for Intangibles.
• The sharpest annual moves came in 2022 and 2023: Intangibles plunged 46.29% in 2022, then plunged 85.71% in 2023.
• A 3-year view of Intangibles shows it stood at $6.9 million in 2021, then sank by 46.29% to $3.7 million in 2022, then plunged by 85.71% to $527000.0 in 2023.
• Business Quant data shows DFTX's Intangibles at $527000.0 in Q4 2023, $1.3 million in Q3 2023, and $2.1 million in Q2 2023.